161 related articles for article (PubMed ID: 32868506)
21. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
[TBL] [Abstract][Full Text] [Related]
22. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
[TBL] [Abstract][Full Text] [Related]
23. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
Koyyada A
Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
[TBL] [Abstract][Full Text] [Related]
24. Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?
Ghosh G; Schnoll-Sussman F; Mathews S; Katz PO
Aliment Pharmacol Ther; 2020 Jan; 51(1):121-128. PubMed ID: 31664732
[TBL] [Abstract][Full Text] [Related]
25. Prescribing PPIs.
Drug Ther Bull; 2017 Oct; 55(10):117-120. PubMed ID: 29021249
[TBL] [Abstract][Full Text] [Related]
26. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.
Kanno T; Moayyedi P
Curr Gastroenterol Rep; 2019 Dec; 21(12):65. PubMed ID: 31807948
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the use of proton pump inhibitors.
Walker NM; McDonald J
Pharm World Sci; 2001 Jun; 23(3):116-7. PubMed ID: 11468876
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors, adverse events and increased risk of mortality.
Lanas-Gimeno A; Hijos G; Lanas Á
Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
[No Abstract] [Full Text] [Related]
29. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors and osteoporosis.
Andersen BN; Johansen PB; Abrahamsen B
Curr Opin Rheumatol; 2016 Jul; 28(4):420-5. PubMed ID: 27224743
[TBL] [Abstract][Full Text] [Related]
31. [Updating in prescription of proton pump inhibitors. What to do and what not to do].
Saiz Ladera GM; Pejenaute Labari ME; García Pascual JN
Semergen; 2021; 47(4):267-279. PubMed ID: 33223372
[TBL] [Abstract][Full Text] [Related]
32. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
33. [New side effects of proton pump inhibitors; time for reflection?].
de Wit NJ; Numans ME
Ned Tijdschr Geneeskd; 2016; 160():D338. PubMed ID: 27334088
[TBL] [Abstract][Full Text] [Related]
34. Rebuilding trust in proton pump inhibitor therapy.
Turshudzhyan A; Samuel S; Tawfik A; Tadros M
World J Gastroenterol; 2022 Jun; 28(24):2667-2679. PubMed ID: 35979162
[TBL] [Abstract][Full Text] [Related]
35. Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.
Schnoll-Sussman F; Katz PO
Curr Treat Options Gastroenterol; 2017 Mar; 15(1):1-9. PubMed ID: 28130652
[TBL] [Abstract][Full Text] [Related]
36. Anaphylaxis due to proton pump inhibitors: current understanding and important clinical considerations.
Benito-Garcia F; Chambel M; Morais-Almeida M
Expert Rev Clin Immunol; 2018 Aug; 14(8):653-656. PubMed ID: 30058396
[TBL] [Abstract][Full Text] [Related]
37. Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.
Farhat N; Fortin Y; Haddad N; Birkett N; Mattison DR; Momoli F; Wu Wen S; Krewski D
Crit Rev Toxicol; 2019 Mar; 49(3):215-261. PubMed ID: 31192763
[TBL] [Abstract][Full Text] [Related]
38. Immediate-Type Hypersensitivity Cross-Reactions to Proton Pump Inhibitors: A Descriptive Study of Data from the French National Pharmacovigilance Database.
Tourillon C; Mahe J; Baron A; Lambert A; Yélehé-Okouma M; Veyrac G; Jolliet P
Int Arch Allergy Immunol; 2019; 178(2):159-166. PubMed ID: 30485850
[TBL] [Abstract][Full Text] [Related]
39. The risks of long-term use of proton pump inhibitors: a critical review.
Jaynes M; Kumar AB
Ther Adv Drug Saf; 2019; 10():2042098618809927. PubMed ID: 31019676
[TBL] [Abstract][Full Text] [Related]
40. [Proton pump inhibitors: not as safe as they seem].
van Herwaarden N; Bos JM; Veldman B; Kramers C
Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
